精神分裂症的分层多尺度框架:整合症状网络、功能环路与分子通路
该研究在精神分裂症多中心队列中整合症状网络分析、基于连接组的预测建模(CPM)和转录组映射,揭示高中心性核心症状在现象学拓扑与生物机制间的分层分离,提出突触与代谢两类分子病因汇聚于「躯体-认知界面」的系统级失败。
要点
- 概念紊乱与异常思维内容临床同属精神病性特征,但神经基质分离。
- 概念紊乱与情感迟钝共享感觉运动网络及皮层下回路连接异常。
- 精神病性网络富集突触调控基因,情感迟钝富集MAPK信号与代谢过程。
核心结论
- 症状可在临床上成组,但治疗需靶向汇聚于共同环路瓶颈的可分离分子通路。
- 该框架调和症状异质性与重叠生物基质,倡导基于机制的精神分裂症分层。
研究设计与样本
- 研究采用整合性多尺度框架,结合症状网络分析、基于连接组的预测建模(CPM)和转录组映射。
- 研究对象为多中心精神分裂症患者队列。
主要发现
- 高中心性核心症状包括概念紊乱、异常思维内容和情感迟钝。
- 概念紊乱与情感迟钝在感觉运动网络(SMN)及皮层下回路呈现汇聚性连接异常。
- 异常思维内容除共享感觉运动基质外,由显著默认模式网络调控驱动。
- 精神病性相关网络由突触调控基因支撑,情感迟钝富集细胞内MAPK信号与代谢过程。
临床怎么用
- 临床可依据症状背后的分子通路差异进行机制-based分层,而非仅按现象学分组。
- 治疗策略可考虑针对突触与代谢通路分别干预,同时关注共同环路瓶颈。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Schizophrenia is characterized by striking symptom heterogeneity, yet the mapping between specific clinical phenotypes and their underlying biological substrates remains elusive. To bridge this gap, we applied an integrative, multi-scale framework combining symptom network analysis, connectome-based predictive modeling (CPM), and transcriptomic mapping in a multi-center cohort of schizophrenia patients. This approach revealed a hierarchical dissociation between phenotypic topology and underlying biological mechanisms among the identified high-centrality core symptoms: Conceptual Disorganization, Unusual Thought Content, and Blunted Affect. While Conceptual Disorganization and Unusual Thought Content exhibited clinical coherence as psychosis-related features, CPM uncovered a divergence in their neural substrates. Conceptual Disorganization shared greater neurofunctional isomorphism with Blunted Affect-characterized by converging dysconnectivity within the Somatomotor Network (SMN) and subcortical circuits-whereas Unusual Thought Content displayed a distinct architecture driven by prominent Default Mode Network regulation beyond the shared sensorimotor substrate. Transcriptomic annotation further stratified these dimensions: psychosis-related networks were underpinned by synaptic regulatory genes, whereas Blunted Affect was enriched for intracellular MAPK signaling and metabolic processes. These findings delineate a hierarchical model in which distinct molecular etiologies-synaptic versus metabolic-cascade into shared systems-level failures at the "somato-cognitive interface". We conclude that while symptoms may group clinically, their treatment requires targeting separable molecular pathways that converge on common circuit bottlenecks. This framework reconciles symptom heterogeneity with overlapping biological substrates, advocating for a mechanism-based stratification of schizophrenia.
引用
- Cheng P, Liu Z, Li X, et al. A hierarchical multi-scale framework for schizophrenia: integrating symptom networks, functional circuits, and molecular pathways. Mol Psychiatry. 2026. PMID: 42218337. doi:10.1038/s41380-026-03668-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。